Nome Químico: (3R,4S,5S,6R)-2-Butyl-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
Sorrisos: O[C@H]1C(C2=CC=C(Cl)C(CC3=CC=C(OCC)C=C3)=C2)(CCCC)O[C@H](CO)[C@@H](O)[C@@H]1O
Inchi: InChI=1S/C61H61N7O7/c69-55(48-22-8-1-9-23-48)62-36-38-64(57(71)50-26-12-3-13-27-50)40-42-66(59(73)52-30-16-5-17-31-52)44-46-68(61(75)54-34-20-7-21-35-54)47-45-67(60(74)53-32-18-6-19-33-53)43-41-65(58(72)51-28-14-4-15-29-51)39-37-63-56(70)49-24-10-2-11-25-49/h1-35H,36-47H2,(H,62,69)(H,63,70)
Stability indicating rp-hplc method for simultaneous estimation of dapagliflozin and saxagliptin in pharmaceutical dosage forms
By Thota, Hanisha; Soundarya, G.
From Journal of Global Trends in Pharmaceutical Sciences (2021), 12(1), 9131-9137
Method development and validation of a stability-indicating reversed-phase liquid chromatographic method for the simultaneous estimation of metformin and dapagliflozin in presence of their degradation products
By Kotecha, Nidhi; Patel, Jayvadan
From International Journal of Pharmaceutical Sciences Review and Research (2019), 56(2), 1-6.
Validation of a newly developed stability indicating RP-liquid chromatographic method for the quantitative determination of dapagliflozin
By Sura, Sreenivasulu; Modalavalasa, Rameswara Rao; Kothapalli, ChandraSekhar B.
From Pharma Chemica (2018), 10(1), 93-102